{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"phosphoenolpyruvate-carboxykinase-deficiency","columns":[{"gene":"","key":"population-f66a9dfeb66072162752","label":"Phosphoenolpyruvate carboxykinase deficiency","mondoId":"MONDO:0017320","onsetQualifier":null,"originColumnKey":"MONDO:0017320/ORPHA:2880","originalViews":[{"key":"MONDO:0017320/ORPHA:2880","label":"Phosphoenolpyruvate carboxykinase deficiency","scopeLabel":"ORPHA:2880","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["034abfac28bc3d5ffa7cf24c29a1f0c8eaf33ca8faa5fd84c6b022808786c9a6","0f774c79426e26eade7460521af5dc5ab75c4823e7e6859b498253d25c9397b4","1aaa791803c5fb738df4acfbc474b4690d3234b9c6e96cc627af82b26191ee0a","26df8e4635671257c9b1baa01dbcb6cd60b94f9fa1fab271f6a30c2fa67673f0","37446b8d55ee68fb2ee04da079c0d0157814cf98fe2ccd110215e712b0c04534","3b539b329c80acf11dc020e4f1e2d7eaef97b4219213dbea263512fe0db8311a","3fbe7303714c2447c1c2c80ea8d041167733e13c1a4af817412ba0717cd9013d","47103cab83a62f616e9a736e574074413c6c8f9313af2951b3f59a7abfce1662","485abe95403fb4b5eea2a9d682b71d283ec568534b0ab374b8b99ef39703daae","502a00bafe81979567e3ba19aa718b576274cfdfca36dd303be4ece983e91837","53d091703db8f41c8daefc45451e300de3f9a19129a16e3af1e5cfc4a7eff0ee","5d26d6f301086eafe176d8bfed1bc0718afd3e46c1621408bafc3e0a86b747f2","8c8a49e9264537995870f7510773aa8c4d3e1a59cef3ea7a04bd6deee447a9be","93ba43f6ad138a5199126ae992b76cd9910a288fafb3586f721b2231df897b97","9ac9915c7205019a398824aeebfb7cc0082a85d7b79170dcd55117940da62fcd","a79d8d9653c8b349290fa74eab072e6837f51ec6d9e3ed9b9202825c1a79952b","b8d010df5733f48899b149a6aafcc4e626ce45c076d44bc7a82bd30a09a819a4","bc0d694dc89dd28d0028258ab41ee615e7087025f18122fb27023c5ec1b8f8b3","c77c89329ad6f862d52894d378657aab38de5938fcccb93e3ea7c986e7055aee","d93ae91c89d9ac325bf3ce33fe6183ad3b6ccfac88bc8125381bd63cfc166563","f020d5e5dce77e1855d6d9815cfe9cb73b300bfcb167f202c13b2d405a0e1a60","fc4d014740f5202619d9184036a5b338ca1fdd57b06c5ac62259d9b425f097ab"],"recordQualifiers":{},"scopeLabel":"ORPHA:2880","sourceIds":["ORPHA:2880"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f66a9dfeb66072162752"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0006846","HP:0001410","HP:0002329","HP:0031964","HP:0031956","HP:0034648","HP:0001397"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"orphanet":22}},"features":[{"hpoId":"HP:0006846","label":"Acute encephalopathy","primary":true},{"hpoId":"HP:0001410","label":"Decreased liver function","primary":true},{"hpoId":"HP:0002329","label":"Drowsiness","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":true},{"hpoId":"HP:0034648","label":"Elevated urine fumaric acid level","primary":true},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":true},{"hpoId":"HP:0001987","label":"Hyperammonemia","primary":false},{"hpoId":"HP:0003217","label":"Hyperglutaminemia","primary":false},{"hpoId":"HP:0001325","label":"Hypoglycemic coma","primary":false},{"hpoId":"HP:0002173","label":"Hypoglycemic seizures","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":false},{"hpoId":"HP:0003648","label":"Lacticaciduria","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0001998","label":"Neonatal hypoglycemia","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0001988","label":"Recurrent hypoglycemia","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"A rare gluconeogenesis disorder that results from impairment in the enzyme phosphoenolpyruvate carboxykinase, and comprised of cytosolic and mitochondrial forms of enzyme deficiency. Onset of symptoms is neonatal or a few months after birth and includes hypoglycemia associated with acute episodes of severe lactic acidosis, progressive neurological deterioration, severe liver failure, renal tubular acidosis and Fanconi syndrome. Patients also present progressive multisystem damage with failure to thrive, muscular weakness and hypotonia, developmental delay with seizures, spasticity, lethargy, microcephaly and cardiomyopathy. This disorder does not typically exist in isolated form.","mondoId":"MONDO:0017320","node":{"canonicalSlug":"phosphoenolpyruvate-carboxykinase-deficiency","comparisons":[{"documentSha256":"6ec6f4823f136739717320eec841055dcafa33ae49c573993470d930416220ec","key":"legacy-phosphoenolpyruvate-carboxykinase-deficiency","kind":"legacy","label":"phosphoenolpyruvate carboxykinase deficiency","memberIds":["MONDO:0009864","MONDO:0009866","MONDO:0017320"],"mondoId":"MONDO:0017320","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/phosphoenolpyruvate-carboxykinase-deficiency.6ec6f4823f136739717320eec841055dcafa33ae49c573993470d930416220ec.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Phosphoenolpyruvate carboxykinase (GTP) deficiency","originalSourceId":"ORPHA:2880","paragraphs":["A rare gluconeogenesis disorder that results from impairment in the enzyme phosphoenolpyruvate carboxykinase, and comprised of cytosolic and mitochondrial forms of enzyme deficiency. Onset of symptoms is neonatal or a few months after birth and includes hypoglycemia associated with acute episodes of severe lactic acidosis, progressive neurological deterioration, severe liver failure, renal tubular acidosis and Fanconi syndrome. Patients also present progressive multisystem damage with failure to thrive, muscular weakness and hypotonia, developmental delay with seizures, spasticity, lethargy, microcephaly and cardiomyopathy. This disorder does not typically exist in isolated form."],"rawAttribution":"MONDO:0017320","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:49:45Z","upstream":"ORPHA:2880","url":"https://rarediseases.info.nih.gov/diseases/16613"},"ownColumnKeys":["population-f66a9dfeb66072162752"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of gluconeogenesis","mondoId":"MONDO:0019225","slug":"disorder-of-gluconeogenesis"},{"kind":"child","label":"phosphoenolpyruvate carboxykinase deficiency, mitochondrial","mondoId":"MONDO:0009864","slug":"phosphoenolpyruvate-carboxykinase-deficiency-mitochondrial"},{"kind":"child","label":"phosphoenolpyruvate carboxykinase deficiency, cytosolic","mondoId":"MONDO:0009866","slug":"phosphoenolpyruvate-carboxykinase-deficiency-cytosolic"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"034abfac28bc3d5ffa7cf24c29a1f0c8eaf33ca8faa5fd84c6b022808786c9a6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0f774c79426e26eade7460521af5dc5ab75c4823e7e6859b498253d25c9397b4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001410","is_excluded":false,"label":"Decreased liver function","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1aaa791803c5fb738df4acfbc474b4690d3234b9c6e96cc627af82b26191ee0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"26df8e4635671257c9b1baa01dbcb6cd60b94f9fa1fab271f6a30c2fa67673f0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001325","is_excluded":false,"label":"Hypoglycemic coma","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"37446b8d55ee68fb2ee04da079c0d0157814cf98fe2ccd110215e712b0c04534","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b539b329c80acf11dc020e4f1e2d7eaef97b4219213dbea263512fe0db8311a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003217","is_excluded":false,"label":"Hyperglutaminemia","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fbe7303714c2447c1c2c80ea8d041167733e13c1a4af817412ba0717cd9013d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"47103cab83a62f616e9a736e574074413c6c8f9313af2951b3f59a7abfce1662","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006846","is_excluded":false,"label":"Acute encephalopathy","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"485abe95403fb4b5eea2a9d682b71d283ec568534b0ab374b8b99ef39703daae","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001988","is_excluded":false,"label":"Recurrent hypoglycemia","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"502a00bafe81979567e3ba19aa718b576274cfdfca36dd303be4ece983e91837","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002173","is_excluded":false,"label":"Hypoglycemic seizures","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"53d091703db8f41c8daefc45451e300de3f9a19129a16e3af1e5cfc4a7eff0ee","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d26d6f301086eafe176d8bfed1bc0718afd3e46c1621408bafc3e0a86b747f2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001998","is_excluded":false,"label":"Neonatal hypoglycemia","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8c8a49e9264537995870f7510773aa8c4d3e1a59cef3ea7a04bd6deee447a9be","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"93ba43f6ad138a5199126ae992b76cd9910a288fafb3586f721b2231df897b97","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ac9915c7205019a398824aeebfb7cc0082a85d7b79170dcd55117940da62fcd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a79d8d9653c8b349290fa74eab072e6837f51ec6d9e3ed9b9202825c1a79952b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001987","is_excluded":false,"label":"Hyperammonemia","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b8d010df5733f48899b149a6aafcc4e626ce45c076d44bc7a82bd30a09a819a4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc0d694dc89dd28d0028258ab41ee615e7087025f18122fb27023c5ec1b8f8b3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034648","is_excluded":false,"label":"Elevated urine fumaric acid level","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c77c89329ad6f862d52894d378657aab38de5938fcccb93e3ea7c986e7055aee","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d93ae91c89d9ac325bf3ce33fe6183ad3b6ccfac88bc8125381bd63cfc166563","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f020d5e5dce77e1855d6d9815cfe9cb73b300bfcb167f202c13b2d405a0e1a60","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003648","is_excluded":false,"label":"Lacticaciduria","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc4d014740f5202619d9184036a5b338ca1fdd57b06c5ac62259d9b425f097ab","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2880","disease_name":"Phosphoenolpyruvate carboxykinase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:2880","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16613\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017320\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:2880</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare gluconeogenesis disorder that results from impairment in the enzyme phosphoenolpyruvate carboxykinase, and comprised of cytosolic and mitochondrial forms of enzyme deficiency. Onset of symptoms is neonatal or a few months after birth and includes hypoglycemia associated with acute episodes of severe lactic acidosis, progressive neurological deterioration, severe liver failure, renal tubular acidosis and Fanconi syndrome. Patients also present progressive multisystem damage with failure to thrive, muscular weakness and hypotonia, developmental delay with seizures, spasticity, lethargy, microcephaly and cardiomyopathy. This disorder does not typically exist in isolated form.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16613\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"phosphoenolpyruvate-carboxykinase-deficiency","sourceDocuments":[{"name":"GARD: Phosphoenolpyruvate carboxykinase (GTP) deficiency","reviewed":null,"source_release":"2026-10-21T15:49:45Z","url":"https://rarediseases.info.nih.gov/diseases/16613"},{"name":"MONDO: phosphoenolpyruvate carboxykinase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017320"}],"sourceNote":"","synonyms":["PEPCK deficiency","phosphoenolpyruvate carboxykinase (GTP) deficiency"],"takeawayHtml":"","title":"phosphoenolpyruvate carboxykinase deficiency"},"schemaVersion":1}
